Clik here to view.
SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China
WATERTOWN, Mass. SQZ Biotechnologies Company (NYSE: SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that its China Initiative has been...
View ArticleClik here to view.
横河电机成功研发出用于亚细胞级采样的Single Cellome系统SS2000
东京 (美国商业资讯)–横河电机株式会社(Yokogawa Electric Corporation, TOKYO:6841)宣布，已成功开发出Single Cellome™系统SS2000，这是一种单细胞分析解决方案，利用共焦显微镜捕获的高分辨率图像，能够自动准确地采集特定细胞和细胞内成分的样本。SS2000将于2022年2月在日本、美国和中国发布，随后将在欧洲等其他市场推出。...
View ArticleClik here to view.
SanBio Joins the Newly Formed National TBI Registry Coalition (NTRC) as a...
TOKYO & MOUNTAIN VIEW, Calif. The SanBio Group (SanBio Co., Ltd. of Tokyo, Japan, SanBio, Inc. of Mountain View, California, US, and SanBio Asia Pte. Ltd. of Singapore) (TSE:4592), today...
View ArticleClik here to view.
Curia Unveils Comprehensive mRNA Solution
ALBANY, N.Y. Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which includes discovery, process...
View ArticleClik here to view.
Babson Graduate Pooja Ika Launches eternalHealth, the First New Medicare...
BOSTON eternalHealth, the first new health plan to be approved in Massachusetts since 2013, has officially announced its launch of the company, delivering high-quality and affordable Medicare...
View ArticleClik here to view.
GC Cell Inks First Licensing Agreement for Immuncell-LC® With Rivaara Immune...
YONGIN, South Korea & MUMBAI, India GC Cell (KOSDAQ:144510) and Rivaara Immune Private Limited today announced that they have entered into an exclusive licensing agreement, pursuant to which...
View ArticleClik here to view.
Cellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of...
TOKYO Cellusion Inc., a regenerative medicine startup aiming to solve the global Corneal transplant waiting list problem with a unique differentiation induction method from iPS cells to Corneal...
View ArticleClik here to view.
Parse Biosciences Announces Partnership With Research Instruments Group to...
SEATTLE Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole...
View ArticleClik here to view.
Bio-Thera Solutions Announces First Patient Dosed in Australia for BAT6021,...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase 1 clinical study to evaluate the pharmacokinetics,...
View ArticleClik here to view.
EdiGene Enters Strategic R＆D Collaboration with Haihe Laboratory of Cell...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious genetic diseases...
View ArticleClik here to view.
ウォーターズが電荷検出質量分析技術を取得し、その細胞・遺伝子治療への応用を拡大
米マサチューセッツ州ミルフォード （ビジネスワイヤ） — ウォーターズコーポレーション (NYSE:WAT) は本日、電荷検出質量分析法 (CDMS) の技術とサービスの初期段階の開発企業であるメガダルトン・ソリューションズの技術資産と知的財産権を取得したと発表しました。本取引の財務的な詳細は公開していません。...
View ArticleClik here to view.
EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive License...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious genetic diseases...
View ArticleClik here to view.
沃特世收购电荷检测质谱技术，扩展其在细胞和基因治疗中的应用
马萨诸塞州米尔福德 (美国商业资讯)–沃特世公司(Waters Corporation, NYSE:WAT)今天宣布已经收购了电荷检测质谱(CDMS)技术和服务早期开发商Megadalton Solutions, Inc.的技术资产和知识产权。该交易的财务细节没有披露。 Megadalton Solutions由印第安纳大学的Martin Jarrold教授和David...
View ArticleClik here to view.
EdiGene Announces Publication by Company Scientific Founder in Nature...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., a global biotechnology company, today announced its Scientific Founder Wensheng Wei’s lab at Peking University has published a research article in...
View ArticleClik here to view.
Trestle Biotherapeutics Announces License Agreement with Kumamoto University...
SAN DIEGO Trestle Biotherapeutics, a private company based in San Diego, today announced that it has entered into a license agreement with Kumamoto University. Under the agreement, Trestle will gain...
View ArticleClik here to view.
Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell...
SEATTLE Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson...
View ArticleClik here to view.
Alofisel®▼ (darvadstrocel) Shows Clinical Remission Rate at Six-Months in the...
OSAKA, Japan & CAMBRIDGE, Massachusetts Takeda (TSE:4502/NYSE:TAK) today announced the first six-month interim analysis results from INSPIRE, in which clinical remission* was observed in 65% of...
View ArticleClik here to view.
Exscientia联合牛津大学启动“Xcellomics”计划，加快早期学术研究，将最新生物学成果转化为未来的药物发现
英格兰牛津 (美国商业资讯)–Exscientia (Nasdaq: EXAI)和牛津大学标靶研发院(Oxford TDI)今天宣布创建Xcellomics项目——一个旨在从全球学术界获取细胞功能检测方案的项目，以开发新的筛选方法，确定面向未满足医疗需求的靶标和候选疗法。...
View ArticleClik here to view.
エクセンシアとオックスフォード大学が早期段階の学術研究を促進して新しい生物学的研究の成果を将来の創薬につなげるXcellomicsプログラムを発足
英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq:...
View ArticleClik here to view.
EdiGene Obtains Worldwide License from Boston Children’s Hospital to Methods...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious genetic diseases...
View Article